The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

Phase 2

Completed

• Conditions: To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients
• Interventions: Drug: Drugs, Investigational

• Registration Number: NCT04205201
• Lead Sponsor: Chittagong Medical College

Brief Summary

Outpatient department of cmch, ceitc,cimch POAG patients enrolled for the study.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-25
• Primary Completion: 2019-09-24
• Study Completion: 2019-10-05
• Status Verified: 2019-12
• Study First Submitted: 2019-12-17
• Study First Submitted QC: 2019-12-17
• Study First Posted: 2019-12-19
• Last Update Submitted: 2019-12-22
• Last Update Posted: 2019-12-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• IOP 22_34mmof Hg,newly diagnosed case, bilateral POAG patients Patients.

Exclusion Criteria

• pregnant and lactating women, infection, any eye surgery.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group A	Drugs, Investigational	Latanoprost
Group B	Drugs, Investigational	Brimonidine

Primary Outcome Measures

Name	Time	Method
More than 20% IOP reduction	0_3 months	From baseline to month 3

Secondary Outcome Measures

Name	Time	Method
Adverse reaction	O_3 months	Record every follow up period baseline to month 3.

Trial Locations

Locations (2)

Facuity of basic science and para clinical science; 🇧🇩 Dhaka, Chittagong, Bangladesh

Facuity of basic scienceand para clinican science; 🇧🇩 Chittagong, Chokhbazar, Bangladesh